Pagé M

No ORCID on file · 6 papers in corpus
article 2004
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1046/j.8755-8920.2003.00138.x

PROBLEM: Many soluble factors contributing to the pathophysiology of endometriosis are found at abnormal levels in patients suffering from the disease. We postulated that levels of these factors could also be altered in the serum of patient…

article 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)00986-5

ObjectiveTo test whether fragments of human endometrium transduced with the green fluorescent protein (GFP) cDNA and transplanted into nude mice can be noninvasively visualized.DesignA murine experimental model for human endometriosis.Setti…

other 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)00552-1

OBJECTIVE: To determine whether blood leukocyte populations could be modulated in endometriosis. DESIGN: Case-control study. SETTING: Eight clinical institutions of the Montreal area. PATIENT(S): Women with regular menstrual cycles who u…

article 2003
Human Reproduction ·doi:10.1093/humrep/deg514

BACKGROUND: Soluble intercellular adhesion molecule-1 (sICAM-1), released by endometriotic lesions, is involved in the regulation of cytotoxic processes. Altered levels of sICAM-1 in the circulation could parallel its deregulation in the pe…

other 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)01153-1

OBJECTIVE: To determine whether the proportion of several leukocyte subsets is modulated in the endometrium of patients with endometriosis and, if yes, whether it can be used for diagnostic purposes. DESIGN: Case-control study. SETTING: E…

article 2003
Human Reproduction ·doi:10.1093/humrep/deg326

BACKGROUND: Elevated concentrations of vascular endothelial growth factor (VEGF) have been detected in the peritoneal fluid of patients with endometriosis. Furthermore, it was postulated that VEGF is involved in the development of endometri…